The above diagram shows the color scheme of the layout in the main result page. The parent entities and officers are those entities, including individual and legal persons, have significant controls over the company in focus. The offspring entities and appointments are those entities that the company in focus can influence on.

Clicking the links on parent entities or officers, and offspring entities or managed companies will put them in focus and show upstream or downstream connections. In general, ascendant entities can be found by moving toward upstream, and descendant entities are by toward downstream. In this way, progenitor entities such as grandparent companies (parents of parent), sibling companies (children of parent), partner companies (parents of child), and progeny entities such as grandchild companies (children of child) can be found easily.

Parent entities and officers
Active 5
  • 1
    Glanvill, Sheryl Anne
    Operations Director born in November 1970
    Individual (3 offsprings)
    Officer
    2015-09-07 ~ now
    OF - Director → CIF 0
  • 2
    Rabin, Joel Stewart
    Director born in February 1974
    Individual (10 offsprings)
    Officer
    2009-01-23 ~ now
    OF - Director → CIF 0
  • 3
    Rabin, Fabienne
    Individual (7 offsprings)
    Officer
    2009-01-23 ~ now
    OF - Secretary → CIF 0
  • 4
    Barry, Christian
    Managing Director born in January 1976
    Individual (13 offsprings)
    Officer
    2015-08-12 ~ now
    OF - Director → CIF 0
  • 5
    Old Station Road, Loughton, Essex, United Kingdom
    Active Corporate (3 parents, 2 offsprings)
    Equity (Company account)
    7,224,346 GBP2023-06-30
    Person with significant control
    2019-05-22 ~ now
    PE - Ownership of shares – 75% or more → CIF 0
    PE - Ownership of voting rights - 75% or more → CIF 0
    PE - Right to appoint or remove directors → CIF 0
Ceased 4
  • 1
    Mr Joel Rabin
    Born in February 1974
    Individual (10 offsprings)
    Person with significant control
    2016-04-06 ~ 2019-05-21
    PE - Ownership of shares – More than 25% but not more than 50% → CIF 0
    PE - Ownership of voting rights - More than 25% but not more than 50% → CIF 0
  • 2
    Jakobsen, David Lars
    Director born in December 1958
    Individual (2 offsprings)
    Officer
    2015-08-12 ~ 2023-12-02
    OF - Director → CIF 0
  • 3
    Mr Barry Christian
    Born in January 1976
    Individual (13 offsprings)
    Person with significant control
    2016-04-06 ~ 2019-05-22
    PE - Ownership of shares – More than 25% but not more than 50% → CIF 0
    PE - Ownership of voting rights - More than 25% but not more than 50% → CIF 0
  • 4
    White, Christina
    Finance Director born in August 1967
    Individual (1 offspring)
    Officer
    2016-08-22 ~ 2020-01-31
    OF - Director → CIF 0
parent relation
Company in focus

TELETA PHARMA LIMITED

Previous name
PHABS PHARMA LIMITED - 2015-08-26
Standard Industrial Classification
46460 - Wholesale Of Pharmaceutical Goods
Brief company account
Average Number of Employees
422022-07-01 ~ 2023-06-30
402021-07-01 ~ 2022-06-30
Turnover/Revenue
16,451,096 GBP2022-07-01 ~ 2023-06-30
15,236,881 GBP2021-07-01 ~ 2022-06-30
Cost of Sales
-13,587,927 GBP2022-07-01 ~ 2023-06-30
-12,594,708 GBP2021-07-01 ~ 2022-06-30
Gross Profit/Loss
2,863,169 GBP2022-07-01 ~ 2023-06-30
2,642,173 GBP2021-07-01 ~ 2022-06-30
Administrative Expenses
-1,959,652 GBP2022-07-01 ~ 2023-06-30
-1,883,745 GBP2021-07-01 ~ 2022-06-30
Operating Profit/Loss
903,517 GBP2022-07-01 ~ 2023-06-30
764,709 GBP2021-07-01 ~ 2022-06-30
Profit/Loss on Ordinary Activities Before Tax
903,517 GBP2022-07-01 ~ 2023-06-30
762,429 GBP2021-07-01 ~ 2022-06-30
Profit/Loss
751,453 GBP2022-07-01 ~ 2023-06-30
648,064 GBP2021-07-01 ~ 2022-06-30
Property, Plant & Equipment
166,094 GBP2023-06-30
204,770 GBP2022-06-30
Fixed Assets - Investments
45 GBP2023-06-30
Fixed Assets
166,139 GBP2023-06-30
204,770 GBP2022-06-30
Total Inventories
1,418,855 GBP2023-06-30
2,017,398 GBP2022-06-30
Debtors
Current
6,106,935 GBP2023-06-30
5,070,575 GBP2022-06-30
Cash at bank and in hand
1,858,444 GBP2023-06-30
1,526,462 GBP2022-06-30
Current Assets
9,384,234 GBP2023-06-30
8,614,435 GBP2022-06-30
Creditors
Current, Amounts falling due within one year
-6,257,825 GBP2023-06-30
-6,268,441 GBP2022-06-30
Net Current Assets/Liabilities
3,126,409 GBP2023-06-30
2,345,994 GBP2022-06-30
Total Assets Less Current Liabilities
3,292,548 GBP2023-06-30
2,550,764 GBP2022-06-30
Net Assets/Liabilities
3,251,025 GBP2023-06-30
2,499,572 GBP2022-06-30
Equity
Called up share capital
100 GBP2023-06-30
100 GBP2022-06-30
100 GBP2021-07-01
Retained earnings (accumulated losses)
3,250,925 GBP2023-06-30
2,499,472 GBP2022-06-30
1,851,408 GBP2021-07-01
Equity
3,251,025 GBP2023-06-30
2,499,572 GBP2022-06-30
1,851,508 GBP2021-07-01
Profit/Loss
Retained earnings (accumulated losses)
751,453 GBP2022-07-01 ~ 2023-06-30
648,064 GBP2021-07-01 ~ 2022-06-30
Comprehensive Income/Expense
Retained earnings (accumulated losses)
751,453 GBP2022-07-01 ~ 2023-06-30
648,064 GBP2021-07-01 ~ 2022-06-30
Comprehensive Income/Expense
751,453 GBP2022-07-01 ~ 2023-06-30
648,064 GBP2021-07-01 ~ 2022-06-30
Audit Fees/Expenses
11,648 GBP2022-07-01 ~ 2023-06-30
10,250 GBP2021-07-01 ~ 2022-06-30
Wages/Salaries
1,164,193 GBP2022-07-01 ~ 2023-06-30
1,075,872 GBP2021-07-01 ~ 2022-06-30
Social Security Costs
128,703 GBP2022-07-01 ~ 2023-06-30
120,006 GBP2021-07-01 ~ 2022-06-30
Staff Costs/Employee Benefits Expense
1,316,031 GBP2022-07-01 ~ 2023-06-30
1,217,408 GBP2021-07-01 ~ 2022-06-30
Director Remuneration
260,664 GBP2022-07-01 ~ 2023-06-30
254,680 GBP2021-07-01 ~ 2022-06-30
Deferred Tax Expense/Credit Relating to Origination/Reversal Timing Differences
-9,669 GBP2022-07-01 ~ 2023-06-30
-8,534 GBP2021-07-01 ~ 2022-06-30
Tax Expense/Credit at Applicable Tax Rate
185,221 GBP2022-07-01 ~ 2023-06-30
144,862 GBP2021-07-01 ~ 2022-06-30
Property, Plant & Equipment - Gross Cost
Motor vehicles
110,050 GBP2023-06-30
110,050 GBP2022-06-30
Furniture and fittings
140,723 GBP2023-06-30
139,969 GBP2022-06-30
Computers
42,745 GBP2023-06-30
37,739 GBP2022-06-30
Property, Plant & Equipment - Gross Cost
293,518 GBP2023-06-30
287,758 GBP2022-06-30
Property, Plant & Equipment - Accumulated Depreciation (Not Including Impairment)
Motor vehicles
13,350 GBP2022-06-30
Furniture and fittings
47,158 GBP2022-06-30
Computers
22,480 GBP2022-06-30
Property, Plant & Equipment - Accumulated Depreciation (Not Including Impairment)
82,988 GBP2022-06-30
Property, Plant & Equipment - Increase From Depreciation Charge for Year
Motor vehicles, Owned/Freehold
13,350 GBP2022-07-01 ~ 2023-06-30
Furniture and fittings, Owned/Freehold
20,998 GBP2022-07-01 ~ 2023-06-30
Computers, Owned/Freehold
10,088 GBP2022-07-01 ~ 2023-06-30
Owned/Freehold
44,436 GBP2022-07-01 ~ 2023-06-30
Property, Plant & Equipment - Accumulated Depreciation & Impairment
Motor vehicles
26,700 GBP2023-06-30
Furniture and fittings
68,156 GBP2023-06-30
Computers
32,568 GBP2023-06-30
Property, Plant & Equipment - Accumulated Depreciation & Impairment
127,424 GBP2023-06-30
Property, Plant & Equipment
Motor vehicles
83,350 GBP2023-06-30
96,700 GBP2022-06-30
Furniture and fittings
72,567 GBP2023-06-30
92,811 GBP2022-06-30
Computers
10,177 GBP2023-06-30
15,259 GBP2022-06-30
Finished Goods/Goods for Resale
1,418,855 GBP2023-06-30
2,017,398 GBP2022-06-30
Trade Debtors/Trade Receivables
Current
1,689,737 GBP2023-06-30
1,884,649 GBP2022-06-30
Other Debtors
Current
3,806,151 GBP2023-06-30
3,092,084 GBP2022-06-30
Prepayments/Accrued Income
Current
550,217 GBP2023-06-30
93,842 GBP2022-06-30
Cash and Cash Equivalents
1,858,444 GBP2023-06-30
1,526,462 GBP2022-06-30
Trade Creditors/Trade Payables
Current
1,288,319 GBP2023-06-30
962,730 GBP2022-06-30
Amounts owed to group undertakings
Current
4,474,121 GBP2023-06-30
264,936 GBP2022-06-30
Corporation Tax Payable
Current
161,733 GBP2023-06-30
122,899 GBP2022-06-30
Taxation/Social Security Payable
Current
234,303 GBP2023-06-30
254,362 GBP2022-06-30
Other Creditors
Current
31,390 GBP2023-06-30
4,621,368 GBP2022-06-30
Accrued Liabilities/Deferred Income
Current
67,959 GBP2023-06-30
42,146 GBP2022-06-30
Creditors
Current
6,257,825 GBP2023-06-30
6,268,441 GBP2022-06-30
Net Deferred Tax Liability/Asset
-41,523 GBP2023-06-30
-51,192 GBP2022-06-30
Profit/Loss - Increase/Decrease in Net Deferred Tax Liability from Amount Recognised
9,669 GBP2022-07-01 ~ 2023-06-30
Deferred Tax Liabilities
Accelerated tax depreciation
-41,523 GBP2023-06-30
-51,192 GBP2022-06-30
Number of Shares Issued (Fully Paid)
Class 1 ordinary share
100 shares2023-06-30
100 shares2022-06-30
Par Value of Share
Class 1 ordinary share
1.002022-07-01 ~ 2023-06-30
Future Minimum Lease Payments Under Non-cancellable Operating Leases
Amounts falling due within one year
114,679 GBP2023-06-30
114,679 GBP2022-06-30
Between one and five year
47,120 GBP2023-06-30
161,799 GBP2022-06-30
Future Minimum Lease Payments Under Non-cancellable Operating Leases
161,799 GBP2023-06-30
276,478 GBP2022-06-30
Related profiles found in government register
  • TELETA PHARMA LIMITED
    Info
    PHABS PHARMA LIMITED - 2015-08-26
    Registered number 06800217
    C/o Haslers, Old Station Road, Loughton, Essex IG10 4PL
    Private Limited Company incorporated on 2009-01-23 (16 years 5 months). The company status is Active.
    The last date of confirmation statement was made at 2024-05-24
    CIF 0
  • TELETA PHARMA LTD
    S
    Registered number 06800217
    C/o Haslers, Old Station Road, Loughton, Essex, United Kingdom, IG10 4PL
    Private Company Limited By Shares in Uk Register Of Companies, United Kingdom
    CIF 1
child relation
Offspring entities and appointments
Active 1
  • 25 Sandyford Place, Glasgow, Scotland
    Active Corporate (5 parents)
    Equity (Company account)
    100 GBP2023-06-30
    Person with significant control
    2022-06-13 ~ now
    CIF 1 - Ownership of shares – More than 25% but not more than 50% → OE
    CIF 1 - Ownership of voting rights - More than 25% but not more than 50% → OE

qrcode

Privacy notice

© 2022-2025 Polylogarithmic Technology Ltd. All rights reserved.
Contains public sector information retrieved at 24 April 2025 and licensed under the Open Government Licence v3.0.